Sterol and Mineral Profiles of the Common Sea Snail Hinia Reticulata and the Long Sea Snail Nassarius Mutabilis (Gastropods) Collected from the Middle Adriatic Sea

Sea snails represent a common food in the world as a source of sterols, such as cholesterol and phytosterol, and minerals. Sterols play important roles in body functions and also minerals are important for human health, so the intake of these nutrients into human diets should be known. The aim of this study was to examine the sterol and mineral profiles of the long (Hinia reticulata) and the common (Nassarius mutabilis) sea snails. Samples of both species were collected at different catch times from November 2019 to March 2020 and transported to the University of Camerino (UNICAM) for the evaluation of their sterol and mineral profiles, including toxic elements (Cd, Cr, Pb). The results of the study showed that the average content of total lipid were 57 mg/100 g, 38 mg/100 g for cholesterol and 19 mg/100 g for phytosterol in the long sea snail, and the values were respectively 68, 48, and 20 mg/100 g in the common sea snail, without significant differences in the two examined sea snails. Additionally, the result of the mineral analysis showed that both species were significant sources of minerals, with negligible levels of toxic metals and metalloids. Therefore, the Long and the Common sea snail are suitable and safety sea products for human nutrition

Synthesis, characterization, and in vitro-in ovo toxicological screening of silibinin fatty acids conjugates as prodrugs with potential biomedical applications

Silibinin (SIL), the most active phytocompound from Silybum marianum (L.), exerts many biological effects but has low stability and bioavailability. To overcome these drawbacks, the current research proposed the synthesis of silibilin oleate (SIL-O) and silibilin linoleate (SIL-L) derivatives as prodrugs with potentially optimized properties for biomedical applications, and the establishment of their in vitro-in ovo safety profiles. The physicochemical characterization of the obtained compounds using density functional theory (DFT) calculations, and Raman and 1H liquid-state nuclear magnetic resonance (NMR) spectroscopy confirmed the formation of SIL-O and SIL-L complexes. Computational predictions revealed that these lipophilic derivatives present a lower drug-likeness score (-29.96 for SIL-O and -23.55 for SIL-L) compared to SIL, but an overall positive drug score (0.07) and no risk for severe adverse effects. SIL-O and SIL-L showed no cytotoxicity or impairment in cell migration at low concentrations, but at the highest concentration (100 µM), they displayed distinct toxicological profiles. SIL-L was more cytotoxic (on cardiomyoblasts - H9c2(2-1), hepatocytes - HepaRG, and keratinocytes - HaCaT) than SIL-O or SIL, significantly inhibiting cell viability (< 60%), altering cellular morphology, reducing cell confluence (< 70%), and inducing prominent apoptotic-like nuclear features. At the concentration of 100 µM, SIL-O presented an irritation score (IS) of 0.61, indicating a lack of irritant effect on the chorioallantoic membrane (CAM), while SIL-L was classified as a slight irritant with an IS of 1.99. These findings outline a more favorable in vitro and in ovo biocompatibility for SIL-O compared to SIL-L, whose applications are dosage-limited due to potential toxicity

Study of the betulin enriched birch bark extracts effects on human carcinoma cells and ear inflammation

<p>Abstract</p> <p>Background</p> <p>Pentacyclic triterpenes, mainly betulin and betulinic acid, are valuable anticancer agents found in the bark of birch tree. This study evaluates birch bark extracts for the active principles composition.</p> <p>Results</p> <p>New improved extraction methods were applied on the bark of <it>Betula pendula</it> in order to reach the maximum content in active principles. Extracts were analyzed by HPLC-MS, Raman, SERS and ¹³C NMR spectroscopy which revealed a very high yield of betulin (over 90%). Growth inhibiting effects were measured <it>in vitro</it> on four malignant human cell lines: A431 (skin epidermoid carcinoma), A2780 (ovarian carcinoma), HeLa (cervix adenocarcinoma) and MCF7 (breast adenocarcinoma), by means of MTT assay. All of the prepared bark extracts exerted a pronounced antiproliferative effect against human cancer cell lines. In vivo studies involved the anti-inflammatory effect of birch extracts on TPA-induced model of inflammation in mice.</p> <p>Conclusions</p> <p>The research revealed the efficacy of the extraction procedures as well as the antiproliferative and anti-inflammatory effects of birch extracts.</p